Document is current
Any future updates will be listed below
-
Authors
Byun, Jae Hyun
Lebeau, Paul F.
Trink, Jackie
Uppal, Nikhil
Lanktree, Matthew B.
Krepinsky, Joan C. https://orcid.org/0000-0002-6761-909X
Austin, Richard C. https://orcid.org/0000-0003-0127-0865
- License Information
-
More Information
Article History
Accepted: 27 January 2025
First Online: 24 February 2025
Competing interests
: R.C.A. is the President and CSO of Systemic Therapeutics Corporation and CSO for Lysogenix Therapeutics. M.B.L. has received speaker and advisory board fees from Otsuka, Reata, Bayer and Sanofi Genzyme. The other authors declare no competing interests.
